Delivery Order V797P2298D-HHSD2002016F89167
Award Date 4/1/16
Potential Completion Date 3/31/17
Potential Value $214K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $102,189,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines. The contract is a definitive, firm fixed-price contract without any set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company also...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC on December 23, 2016 for the 2017 adult flu season. The firm fixed price contract has a ceiling value of $12,408,000.00 and a performance period ending February 28, 2018. The contract does not have a set-aside designation. GlaxoSmithKline, a pharmaceutical company, has provided a range of products to U.S. government agencies through federal contracts, including influenza...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $62,089,503.55 firm fixed price contract to Glaxosmithkline, LLC to provide vaccines for adults. The contract, which has no set-aside designation, runs from July 1, 2015 to June 30, 2016 and is for the company's pharmaceutical products and vaccine services. Glaxosmithkline, a foreign-owned for-profit organization, has provided a range of vaccines and antiviral medications to various federal agencies through both contracts and...
- This federal contract award was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to the prime contractor Glaxosmithkline, LLC. The $208,994.06 firm fixed price delivery order is for the provision of vaccines, with no set-aside designation. It was issued against Glaxosmithkline's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract supports the government's disease prevention and immunization efforts,...
- This federal contract award is for GLAXO VACCINES FOR STOCK, awarded to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract has a ceiling value of $152,732.80 and is a Delivery Order issued under Glaxosmithkline's Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs. The contract is for a firm fixed price and has no set-aside designation. The contract...
- This is a federal contract award from the U.S. Department of Health and Human Services to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of vaccines. The contract has a ceiling value of $220,298.59 and is a firm fixed price delivery order placed against Glaxosmithkline's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract has no set-aside designation. The contract supports the government's vaccine stockpiling...
- This federal contract award, valued at $82,435.00, was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of vaccines for the government's stockpile. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price. The contract has no set-aside designation and the place of performance is at GlaxoSmithKline's facilities in...
- This is a federal contract award to GlaxoSmithKline, LLC, a pharmaceutical company, by the Centers for Disease Control and Prevention (CDC) for the provision of influenza vaccines. The contract, valued at $9,888,000.00, is a definitive contract with a firm fixed price. The award was made on December 18, 2015, and the ultimate completion date is February 28, 2017. The contract has no set-aside designation, and the place of performance is in Research Triangle Park, North Carolina....
- This is a $84,710,550.00 definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Glaxosmithkline, LLC for the provision of adult vaccines. The contract is a firm fixed price arrangement with no set-aside designation. Glaxosmithkline is a pharmaceutical company that supplies a range of vaccines and antiviral medications to various U.S. government agencies through federal contracts. This award supports the CDC's adult immunization...
- This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...